1-4 of 4
Joe Birkett, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Promising Efficacy with the New Anti-CD20 Antibody GA101 In Heavily Pre-Treated NHL Patients – Updated Results with Encouraging Progression Free Survival (PFS) Data From a Phase II Study In Patients with Relapsed/Refractory Indolent NHL (iNHL)

Gilles Andre Salles, MD, PhD, Franck Morschhauser, MD, PhD, Catherine Thieblemont, MD, PhD, Philippe Solal-Céligny, MD, Thierry Lamy, MD, PhD, Herve Tilly, MD, Pierre Feugier, MD, PhD, Steven Le Gouill, MD, Emmanuel Gyan, MD, PhD, Reda Bouabdallah, MD, Michael Wenger, MD, Joe Birkett, PhD, Guillaume Cartron, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2868.
https://doi.org/10.1182/blood.V116.21.2868.2868
Published: 2010
Journal Articles

Promising Efficacy with the New Anti-CD20 Antibody GA101 In Heavily Pre-Treated NHL Patients – First Results From a Phase II Study In Patients with Relapsed/Refractory DLBCL and MCL

Guillaume Cartron, MD, PhD, Catherine Thieblemont, MD, PhD, Philippe Solal-Celigny, MD, Franck Morschhhauser, MD, PhD, Corinne Haioun, MD, Reda Bouabdallah, MD, Thierry Lamy, MD, PhD, Noel Milpied, MD, Steven Le Gouill, MD, Pierre Feugier, MD, PhD, Joe Birkett, PhD, Michael K. Wenger, MD, Elina Asikanius, Gilles Salles
Journal: Blood
Blood (2010) 116 (21): 2878.
https://doi.org/10.1182/blood.V116.21.2878.2878
Published: 2010
Journal Articles

Comparison of Single Agent GA101 In Japanese and European Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (B-NHL) – Results From Two Phase I Studies

Michinori Ogura, MD, PhD, Franck Morschhauser, MD, PhD, Kensei Tobinai, MD, PhD, Guillaume Cartron, MD, PhD, Kiyohiko Hatake, MD, PhD, Michael K. Wenger, MD, Joe Birkett, PhD, Naoko Oya, Kiyomi Nishima, Gilles Salles, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4921.
https://doi.org/10.1182/blood.V116.21.4921.4921
Published: 2010
Journal Articles

Pharmacokinetics of RO5072759 (GA101) In Patients with Relapsed/Refractory CD20 + Malignant Disease (Phase I/II Study BO20999)

Georgina Meneses-Lorente, PhD, David Carlile, PhD, Joe Birkett, PhD, Michael K. Wenger, MD, Guillaume Cartron, MD, PhD, Franck Morschhauser, MD, PhD, Gilles Andre Salles, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1833.
https://doi.org/10.1182/blood.V116.21.1833.1833
Published: 2010